home / stock / ctxr / ctxr news

CTXR News and Press, Citius Pharmaceuticals Inc.

Stock Information
Company Name: Citius Pharmaceuticals Inc.
Stock Symbol: CTXR
Market: NASDAQ
Website: citiuspharma.com
Menu
CTXR CTXR Quote CTXR Short CTXR News CTXR Articles CTXR Message Board
Get CTXR Alerts

News, Short Squeeze, Breakout and More Instantly...
CTXR - Biotech/Pharma Stocks to Watch Citius Pharmaceuticals, Soligenix, Takeda, Pfizer

2024-07-18 10:20:00 ET July 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compa...
CTXR - Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com , a go-to investing platform releases the second of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a late-stage biopharmaceutical c...

CTXR - Analysts Hunt for Undervalued Biotech Stocks - Citius Pharmaceuticals, Jazz Pharmaceuticals, CRISPR, Krystal Biotech

2024-07-17 10:10:00 ET July 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmaceutical compan...

CTXR - Analysts Hunt for Undervalued Biotech Stocks

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 17, 2024) - Investorideas.com , a go-to investing platform releases the first of a two-part series looking at biotech/biopharma stocks, featuring Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a late-stage biopharmaceutical co...
CTXR - Bloodstream Infections - From Threats to Solutions; Stocks to Watch

2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...

CTXR - Bloodstream Infections - From Threats to Solutions

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. (NA...

CTXR - Transformative Biopharma Stocks - Citius Pharmaceuticals, Vertex Pharmaceuticals, CRISPR Therapeutics, Recursion

2024-07-11 10:10:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at transformative innovation in biopharma, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:CTXR ), a late-stage biopharmac...
CTXR - Biopharma Stocks Transformative Innovation for the Future of Health

Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com , a go-to investing platform releases the first of a two-part series looking at transformative innovation in biopharma, featuring Citius Pharmaceuticals, Inc. (NASDAQ: CTXR), a late-stage biophar...

CTXR - Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates

Citius Pharmaceuticals Details Near-Term Milestones for Late-Stage Candidates PR Newswire Multiple catalysts for potentially transformative assets in second half of 2024 Strong momentum expected from positive topline results of Phase 3 Mino-Lok ® trial, comm...

CTXR - Sidoti Events, LLC's Virtual June Small-Cap Conference

NEW YORK, NY / ACCESSWIRE / June 11, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Conference taking place Wednesday and Thursday, June 12-13, 2024. The presentation schedule is subject to ...
Next 10